Work

AML-1351: MRD-Guided Risk Stratification in Venetoclax-Treated Newly Diagnosed AML: A Pooled Survival Analysis

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)01936-1

Authors: Tooba Nihal, Ayesha Nawal, Aima Azhar, Jawad Ahmed, Asad Ullah Farooq, Mifrah Rahat Khan SherwaniMBBS, Nuri Tamanna, Anid Hassan, Faisal Ansari, Sheraz Qasim, Haider Bin Khalid

Institutions: Allama Iqbal Medical College, Wayne State University, Detroit Medical Center, Community Health Systems - Northwest Health - Porter, King Edward Medical University, Duke University Hospital, SUNY Upstate Medical University, Jersey Shore University Medical Center, Loma Linda University, Geisinger Health System

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204727339

Cites:

Cited by:

Related to: 10